{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:38:08Z","timestamp":1791920288304,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Trimethylamine-N-oxide (TMAO) is a circulating biomarker associated with cardiovascular disease (CVD). Production of TMAO is facilitated by gut microbiota and dependent on micronutrients such as choline, betaine, and L-carnitine, present in foods such as red meat and eggs.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Hypothesis<\/jats:title>\n                <jats:p>We sought to predict serum TMAO quartile levels among healthy individuals at increased risk of CVD using clinical data via an ordinal logistic model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from participants (n\u2009=\u2009127) enrolled in a longitudinal observational study on CVD were used to build a predictive model for TMAO using ordinal logistic regression with demographic variables and 40 other variables considered related to CVD risk. First, univariate models for each covariate were tested (with serum TMAO quartiles as the dependent variable), and only variables with <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.30 were evaluated further. Second, demographic variables (age, gender, white vs. non-white race) were included in a multivariable model with each previously identified independent variable controlling for potential confounding. Last, the final model included fixed demographics and candidates from the confounder-adjusted model with <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.10.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight candidate variables were included in the final model, with only transferrin, high-density lipoprotein cholesterol (HDL-C) and race (white vs. non-white) showing significant associations with TMAO. Participants had 0.16 (Q2), 0.31 (Q3), and 0.20 (Q4) odds of being in a higher TMAO quartile compared with participants in the lowest transferrin quartile. Non-white participants had 2.92 times higher odds of being in the highest TMAO quartile compared to white individuals. Participants in the second quartile of HDL-C had 2.68 times higher odds of being in a higher TMAO quartile compared with participants in the lowest HDL-C quartile.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Transferrin demonstrated a significant predictive association with TMAO and may represent a novel potential biomarker of increased CVD risk worthy of further study. These results warrant further examination of iron, metabolism, homeostasis, and gut microbiome to better understand and mitigate known increased CVD risk.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02644-3","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:02:59Z","timestamp":1652166179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Lamuel D.","family":"Bean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha V.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Wesley","family":"Milks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2644_CR1","unstructured":"CDC. Heart disease facts. Center for disease control and prevention. 2021. https:\/\/www.cdc.gov\/heartdisease\/facts.htm."},{"key":"2644_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/1947-2714.132916","volume":"6","author":"S Roy","year":"2014","unstructured":"Roy S. Atherosclerotic cardiovascular disease risk and evidence-based management of cholesterol. N Am J Med Sci. 2014;6:191.","journal-title":"N Am J Med Sci"},{"key":"2644_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-015-0634-1","volume":"15","author":"D Li","year":"2015","unstructured":"Li D, Kirsop J, Tang WH. Listening to our gut: contribution of gut microbiota and cardiovascular risk in diabetes pathogenesis. Curr Diabetes Rep. 2015;15:1\u20139.","journal-title":"Curr Diabetes Rep"},{"key":"2644_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2020.12.001","volume":"152","author":"P Mamic","year":"2021","unstructured":"Mamic P, Chaikijurajai T, Tang WW. Gut microbiome-A potential mediator of pathogenesis in heart failure and its comorbidities: state-of-the-art review. J Mol Cell Cardiol. 2021;152:105\u201317.","journal-title":"J Mol Cell Cardiol"},{"key":"2644_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26745","volume":"6","author":"E Randrianarisoa","year":"2016","unstructured":"Randrianarisoa E, Lehn-Stefan A, Wang X, et al. Relationship of serum trimethylamine n-oxide (tmao) levels with early atherosclerosis in humans. Sci Rep. 2016;6:1\u20139.","journal-title":"Sci Rep"},{"key":"2644_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"ZKE Wang","year":"2011","unstructured":"Wang ZKE, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57\u201363.","journal-title":"Nature"},{"key":"2644_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0035-1569330","volume":"124","author":"M Dambrova","year":"2016","unstructured":"Dambrova M, Latkovskis G, Kuka J, Strele I, et al. Diabetes is associated with higher trimethylamine n-oxide plasma levels. Exp Clin Endocrinol Diabetes. 2016;124:251\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2644_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WW Tang","year":"2013","unstructured":"Tang WW, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575\u201384.","journal-title":"N Engl J Med"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Hazen SL. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576\u201385.","journal-title":"Nat Med"},{"key":"2644_CR10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.amjmed.2021.03.016","volume":"134","author":"JSS Wilcox","year":"2021","unstructured":"Wilcox JSS, Graham B, Zabell A, Li XS, Li L, Shelkay S, Fu X, Neale S, O\u2019Laughlin C, Peterson K, Hazen SL, Tang WHW. Dietary choline supplements, but not eggs, raise fasting tmao levels in participants with normal renal function: a randomized clinical trial. Am J Med. 2021;134:1160\u20139.","journal-title":"Am J Med"},{"key":"2644_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","volume":"40","author":"Z Wang","year":"2019","unstructured":"Wang Z, Bergeron N, Levison BS, et al. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine n-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2019;40:583\u201394.","journal-title":"Eur Heart J"},{"issue":"5","key":"2644_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.numecd.2019.02.003","volume":"29","author":"JE Park","year":"2019","unstructured":"Park JE, Miller M, Rhyne J, Wang Z, Hazen SL. Differential effect of short-term popular diets on tmao and other cardio-metabolic risk markers. Nutr Metab Cardiovasc Dis. 2019;29(5):513\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2644_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1080\/09637486.2016.1256379","volume":"68","author":"AM Malinowska","year":"2017","unstructured":"Malinowska AM, Szwengiel A, Chmurzynska A. Dietary, anthropometric, and biochemical factors influencing plasma choline, carnitine, trimethylamine, and trimethylamine-n-oxide concentrations. Int J Food Sci Nutr. 2017;68:488\u201395.","journal-title":"Int J Food Sci Nutr"},{"key":"2644_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2018-317155","volume":"68","author":"WK Wu","year":"2019","unstructured":"Wu WK, Chen CC, Liu PY, et al. Alidentification of tmao-producer phenotype and host\u2013diet\u2013gut dysbiosis by carnitine challenge test in human and germ-free mice. Gut. 2019;68:1439\u201349.","journal-title":"Gut"},{"key":"2644_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.atherosclerosis.2015.03.032","volume":"241","author":"SV Raman","year":"2015","unstructured":"Raman SV, Sharkey-Toppen TP, Tran T, et al. Iron, inflammation and atherosclerosis risk in men vs. Perimenopausal women. Atherosclerosis. 2015;241:249\u201354.","journal-title":"Atherosclerosis"},{"key":"2644_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.jvs.2014.02.006","volume":"61","author":"MW Winner III","year":"2015","unstructured":"Winner MW III, Sharkey-Toppen T, Zhang X, Pennell ML, Simonetti OP, Zweier JL, Vaccaro PS, Raman SV. Iron and noncontrast magnetic resonance T2* as a marker of intraplaque iron in human atherosclerosis. J Vasc Surg. 2015;61:1556\u201364.","journal-title":"J Vasc Surg"},{"key":"2644_CR17","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"P Poirier","year":"2006","unstructured":"Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation. 2006;113:898\u2013918.","journal-title":"Circulation"},{"key":"2644_CR18","doi-asserted-by":"crossref","unstructured":"Liu Y, Dai M. Trimethylamine n-oxide generated by the gut microbiota is associated with vascular inflammation: new insights into atherosclerosis. Mediat Inflamm. 2020.","DOI":"10.1155\/2020\/4634172"},{"key":"2644_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-019-0097-2","volume":"5","author":"F La Carpia","year":"2019","unstructured":"La Carpia F, Wojczyk BS, Annavajhala MK, et al. Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron. NPJ Biofilms Microb. 2019;5:1\u201311.","journal-title":"NPJ Biofilms Microb"},{"key":"2644_CR20","first-page":"117","volume":"5","author":"D Basuli","year":"2014","unstructured":"Basuli D, Stevens RG, Torti FM, Torti SV. Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol. 2014;5:117.","journal-title":"Front Pharmacol"},{"key":"2644_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1359-6446(04)03333-1","volume":"10","author":"PT Gomme","year":"2005","unstructured":"Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov today. 2005;10:267\u201373.","journal-title":"Drug Discov today"},{"key":"2644_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3961\/jpmph.2012.45.3.196","volume":"45","author":"KS Kim","year":"2012","unstructured":"Kim KS, Son HG, Hong NS, Lee DH. Associations of srum ferritin and transferrin % saturation with all cause, cancer and cvd disease mortlatiy: third national health and nutriton exmaination sruvey follow-up study. J Prevent Med Public Health. 2012;45:196.","journal-title":"J Prevent Med Public Health"},{"key":"2644_CR23","doi-asserted-by":"publisher","first-page":"e015480","DOI":"10.1161\/JAHA.119.015480","volume":"9","author":"H Weidmann","year":"2020","unstructured":"Weidmann H, Bannasch JH, Waldeyer C, Shrivastava A, Appelbaum S, Ojeda-Echevarria FM, Schnabel R, Lackner KJ, Blankenberg S, Zeller T, Karakas M. Iron metabolism contributes to prognosis in coronary artery disease: prognostic value of the soluble transferrin receptor within the artherogene study. J Am Heart Assoc. 2020;9:e015480.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR24","doi-asserted-by":"crossref","unstructured":"Lanser L, Fuchs D, Scharnagl H, Grammer T, Kleber ME, M\u00e4rz W, Weiss G, Kurz K. Anemia of chronic disease in patients with cardiovascular disease. Front Cardiovasc Med. 2021.","DOI":"10.3389\/fcvm.2021.666638"},{"key":"2644_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/biomedicines9050558","volume":"9","author":"N Fedotcheva","year":"2021","unstructured":"Fedotcheva N, Olenin A, Beloborodova N. Influence of microbial metabolites on the nonspecific permeability of mitochondrial membranes under conditions of acidosis and loading with calcium and iron ions. Biomedicines. 2021;9:558.","journal-title":"Biomedicines"},{"key":"2644_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1080\/10715760310001600390","volume":"37","author":"AV Campenhout","year":"2003","unstructured":"Campenhout AV, Van Campenhout CM, Lagrou AR, Manuel-y-Keenoy B. Transferrin modifications and lipid peroxidation: Implications in diabetes mellitus. Free Radic Res. 2003;37:1069\u201377.","journal-title":"Free Radic Res"},{"key":"2644_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2337\/dc05-2471","volume":"29","author":"DH Lee","year":"2006","unstructured":"Lee DH, Liu DY, Jacobs DR Jr, Shin HR, Song K, Lee IK, Kim B, Hider RC. Common presence of non\u2013transferrin-bound iron among patients with type 2 diabetes. Diabetes Care. 2006;29:1090\u20135.","journal-title":"Diabetes Care"},{"key":"2644_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00592-014-0646-3","volume":"52","author":"N Wlazlo","year":"2014","unstructured":"Wlazlo N, Van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, Van Der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD. Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: The codam study. Acta Diabetol. 2014;52:337\u201348.","journal-title":"Acta Diabetol"},{"key":"2644_CR29","doi-asserted-by":"crossref","unstructured":"Li X, Danielson K, Forsal I, et al. Inverse association of transferrin saturation with mortality risk in chronic kidney disease. Nephrol Dial Transplant. 2020.","DOI":"10.21203\/rs.3.rs-20186\/v1"},{"key":"2644_CR30","first-page":"295","volume":"30","author":"H Healy","year":"2000","unstructured":"Healy H, Reith D, Morgan C, Clague A, Westhuyzen J. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure? Ann Clin Lab Sci. 2000;30:295\u2013304.","journal-title":"Ann Clin Lab Sci"},{"key":"2644_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1194-2","volume":"18","author":"E Org","year":"2017","unstructured":"Org E, Blum Y, Kasela S, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the metsim cohort. Genome Biol. 2017;18:1\u20134.","journal-title":"Genome Biol"},{"issue":"18","key":"2644_CR32","doi-asserted-by":"publisher","first-page":"e012729","DOI":"10.1161\/JAHA.119.012729","volume":"8","author":"E Hackler III","year":"2019","unstructured":"Hackler E III, Lew J, Gore MO, Ayers CR, Atzler D, Khera A, Rohatgi A, Lewis A, Neeland I, Omland T, De Lemos JA. Racial differences in cardiovascular biomarkers in the general population. J Am Heart Assoc. 2019;8(18):e012729.","journal-title":"J Am Heart Assoc"},{"key":"2644_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1573403X11666141122220003","volume":"11","author":"G Graham","year":"2015","unstructured":"Graham G. Disparities in cardiovascular disease risk in the united states. Curr Cardiol Rev. 2015;11:238\u201345.","journal-title":"Curr Cardiol Rev"},{"key":"2644_CR34","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","volume":"167","author":"KWA Mahdy Ali","year":"2012","unstructured":"Mahdy Ali KWA, Huber K, Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol\u2013current therapies and future opportunities. Br J Pharmacol. 2012;167:1177\u201394.","journal-title":"Br J Pharmacol"},{"key":"2644_CR35","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3390\/ijms19103228","volume":"19","author":"M Canyelles","year":"2018","unstructured":"Canyelles M, Tondo M, Ced\u00f3 L, Farr\u00e0s M, Escol\u00e0-Gil JC, Blanco-Vaca F. Trimethylamine N-oxide: a link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function. Int J Mol Sci. 2018;19:3228.","journal-title":"Int J Mol Sci"},{"key":"2644_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet M, Barrett TJ, Fisher EA. Hdl and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease. Circ Res. 2019;124:1505\u201318.","journal-title":"Circ Res"},{"key":"2644_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"HA Lee","year":"2020","unstructured":"Lee HA, An H. The effect of high carbohydrate-to-fat intake ratios on hypo-hdl-cholesterolemia risk and hdl-cholesterol levels over a 12-year follow-up. Sci Rep. 2020;10:1\u20139.","journal-title":"Sci Rep"},{"key":"2644_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3945\/ajcn.115.121269","volume":"103","author":"RAH Obeid","year":"2016","unstructured":"Obeid RAH, Rabagny Y, Graeber S, Herrmann W, Geisel J. Plasma trimethylamine n-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr. 2016;103:703\u201311.","journal-title":"Am J Clin Nutr"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02644-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:03:53Z","timestamp":1652166233000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02644-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02644-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ohio State University\u2019s Institutional Review Board approved the study (#2008H0308), compliant with the Declaration of Helsinki and all relevant regulations and guidelines, and all subjects provided written informed consent to participate prior to completing any study activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, no information or images that could lead to identification of participants are in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}